anti-diabetic drug

anti-diabetic drug News

CSIR launches ayurvedic anti-diabetic drug

Developed jointly by NBRI and CIMAP, the research units of CSIR situated at Lucknow, BGR-34 has been economically priced at Rs 5 per tablet as compared to the latest DPP4 inhibitors, globally.

Common anti-diabetic drug may slow ageing

Metformin, the world's most widely used anti-diabetic drug, may slow ageing and increase lifespan, a new study suggests.

Advertising

USFDA okays safer diabetes drug which acts on kidneys

A novel anti-diabetic drug that lowers blood glucose levels by acting on the kidneys,instead of the liver or the pancreas,has been approved by the USFDA

Popular anti-diabetic drug likely to be banned

Drug Controller General of India (DCGI) is likely to take up the issue of a complete ban on the widely used anti-diabetic drug,rosiglitazone.

India stops import,manufacture of anti-diabetes drug

The Drug Controller General of India (DCGI) Thursday suspended manufacturing and import of the anti-diabetic drug Rosiglitazone.

Advertising